Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects.

Geroscience · 2022 · PMC8612119 · PMID 34820764

Europe PMC DOI

hedged sentences

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

did not reach statistical significancep = 0.09so close (0.05 < p ≤ 0.1)

After 21 days, three cycles of administration, MCOPPB treatment tended to increase the body weight, although this did not reach statistical significance ( p = 0.09, Fig. 2B ).

also in 111,027 other papers

a decreasing trendno p-value reported

A decreasing trend ( p value: 0.096) was also observed in DOX-treated HepG2 cells (Fig. 1D ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.